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Nosocomial hepatitis C virus (HCV) infections were recorded in the renal transplantation
unit of the university hospital. There were cases of acute HCV infection with aggressive
clinical courses diagnosed from a positive HCV RNA test in the early post-transplanta-
tion period and which remained anti-HCV negative. Their anti-HCV seronegativity was
attributed to them having acquired HCV under intense immunosuppressive therapy and
suggested that the aggressive clinical course could be due to the deficient immune
response resulting in an inability to limit viral replication. There were also donors
diagnosed as having acute HCV infection in the early post-operative period. Genotyping
and sequence analysis for HCV were performed on the isolates of eight of these patients
who were consecutively transplanted and of three donors whose recipients were infected
with HCV prior to transplantation, and who acquired acute HCV infection after
transplantation. Of the eight recipients in the first group three were genotype la, three
were genotype Ib, one was genotype 3a, and the last one was genotype 4 according to
Simmond's classification. Of the three donor-recipient couples both the HCV isolates
from one couple were genotyped as Ib and the phylogenetic analysis indicated that the
patients were infected with a common variant of HCV, but the genotypes of HCV isolates
from the other couples were different. Recipients were genotype Ib and the donors were
genotype la in these couples. Genotype results of the first group and donor-recipient
couples, and sequence analysis of genotype Ib and la isolates, showed that the source of
infection was not a unique strain and there were multiple breaks in universal precautions
while managing these patients.
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Hemodialysis patients and renal transplantation
recipients are at high risk for hepatitis C virus
(HCV) infection. Known sources for this infection
in these groups of patients are blood transfusions,
hemodialysis and receiving kidneys from infected
donors, but other nosocomial routes of transmis-
sion have also been reported [1-4].
This study was presented as a poster at the 8th International
Congress on Infectious Diseases, Boston, MA, USA, May 15-
18, 1998.
Three hundred and fifty-two renal transplanta-
tions were performed in the Ege University Organ
Transplantation Centre between 1988 and 1998.
All donors and recipients are screened for HCV
antibody before transplantation, however, HCV-
positive recipients are accepted for transplantation
in this center. It was noticed that there were cases
with acute C hepatitis in the early post-transplan-
tation period in a group of these patients. They
were diagnosed as acute C hepatitis by HCV RNA
test (Amplicor, Roche Diagnostics, Branchburg,
NJ, USA), since their antibodies for HCV (UBI-
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HCV, United Biomedical Inc., Hauppauge, NY,
USA) were negative. These were evaluated as
nosocomial infections and it was planned to deter-
mine the nature of this infection.
The recognition of nosocomial HCV infection in
this unit was of acute hepatitis C cases in the early
post-operative period who underwent an aggres-
sive clinical course and progressed rapidly to
cirrhosis as previously reported by Ok et al. [5].
These patients were seronegative for anti-HCV,
but positive for HCV RNA in serum. The lack of
an antibody response in these recipients may have
resulted from them acquiring HCV under intense
immunosuppression, and the aggressive clinical
course could be due to deficient immune response.
The finding of anti-HCV negativity in 34% of the
HCV RNA-positive recipients supports the first
hypothesis [6].
HCV infections in the early post-transplant per-
iod were evaluated as pre- or post-transplantation
acquired infections. It had been questioned if those
patients had been infected during hemodialysis
and were seronegative because of immunosup-
pression due to renal deficiency. The preoperative
anti-HCV status of each recipient was known, but
HCV RNA status was not known. Anti-HCV posi-
tivity in the hemodialysis unit was 45.7% and sero-
negative HCV RNA positivity was not observed
unless there was a recent infection as previously re-
ported [7]. HCV RNA screening of pre-transplant
recipients was also started after the recognition of
these cases. There were three donors who became
HCV infected. These observations led to a conclu-
sion that those nosocomial HCV infections could
have been acquired during or after transplantation.
Two interesting groups of patients with noso-
comial HCV infection were recognized during
follow-up. The first group consisted of renal trans-
plant recipients who were transplanted consecu-
tively every other week after a pre-operatively
HCV-infected patient, and had acute HCV hepa-
titis at the early post-transplant period. In the first
group there was a total of eight recipients; four of
them were transplanted between 15 November
and 6 December 1993 and four others were trans-
planted between 3 March and 4 April 1994. The
second group consisted of three donor-recipient
couples whose recipients were HCV-infected pre-
transplant and the donors became HCV positive.
These two representative groups were chosen for
investigation by genotyping and phylogenetic
analysis.
The study was designed to investigate the phy-
logenetic relationship of HCV sequences respon-
sible for nosocomial infection in two groups of
patients. HCV isolates were genotyped using
restriction fragment length polymorphism (RFLP)
analysis of nested 5' non-coding region (NCR)
reverse transcription-polymerase chain reaction
products as previously described [8]. Amplifica-
tion of NS5B from HCV sequences utilized outer
primers 1203 and 1204, and biotinylated inner
primers 123 and 122 [9]. Biotinylated products
were immobilized on streptavidin-coated mag-
netic beads (Dynabeads M280, Dynal A/S, Oslo,
Norway) and single strands were sequenced
directly using T7 DNA polymerase (SEQUENASE
version 2.0, USB, Cleveland, OH, USA) according
to the manufacturer's instructions. Sequencing
was performed in the University of Edinburgh.
Phylogenetic analysis of sequences was carried out
on a 248-base pair fragment in the NS5B region
corresponding to nucleotide positions 7964-8211
in the HCV type la clone, HCV-PT [10]. The
nucleotide sequences of group I were aligned with
other sequences from GenBank by CLUSTAL W
version 1.7. Phylogenetic analysis of sequences
from the NS5 region of type la and Ib sequences
using neighbor-joining on nucleotide distances
was calculated using Jukes-Cantor correction for
multiple substitution. The phylogenetic tree con-
structed by TREECON for Windows version 1.3b.
Of the eight recipients who were consecutively
transplanted in group I, three genotype la, three
genotype Ib, one genotype 3a, and one genotype 4
HCV sequences were identified (Table 1).
Of the three donor-recipient couples, one cou-
ple was infected with genotype Ib, whereas the
remaining two recipients were infected with type
Ib while the donors were infected with type la
(Table2). Predominant genotypes were Ib and la
in our study. Genotype distribution in Turkish
Table 1 Genotyping results of group I
Patient no Date of transplantation Genotype
1 15.11.1993 1b
2 22.11.1993 1a
3 29.11.1993 1a
4 06.12.1993 1b
5 21.03.1994 1a
6 23.03.1994 3a
7 28.03.1994 1b
8 04.04.1994 4
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Table 2 Genotyping results of
group II Recipient Donor
Couple no. Patient no. Genotype Patient no. Genotype
1 9 1b 12 1a
2 10 1b 13 1b
3 11 1b 14 1a
4
In conclusion, concerning these strains of noso-
comial HCV infection in this centre there was no
traceable source of infection among sequentially
transplanted recipients. There were different gen-
otypes and unrelated HCV isolates in phylogenetic
analysis. There was one couple with a related
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Figure1 Phylogenetic tree of 1b and 1a HCV NS5B region
sequences of the isolates from six recipients in group I. The
GenBank accession numbers of the HCV 1a and 1b
sequences used in phylogenetic analysis are: genotype 1a
sequences, AF071979, AF071966, AF071964, AF071975,
AF071982, AF071986, AF071963; genotype 1b sequences,
AF071976, AF071957, AF071962, AF071978, AF071973,
AF071963.
renal transplant recipients was previously
reported as being 73.4% genotype Ib, 24.4% geno-
type la and 2.2% genotype 4 [11]. The phylogenetic
tree analysis showed two type 1b sequences from
patients 4 and 7 and type la sequences from
patients 2, 3 and 5 in group I were clustered closely
with high bootstrap values (Figure 1). Type Ib
sequences isolated from patients 1 and 4 seem
not to be related, while type 1b sequences from
patients 4 and 7 showed some evidence of linkage.
However, patient 7 was transplanted 4 months
after patient 4. Type la sequences isolated from
patients 2 and 3 grouped together with sequence 5,
but there were 4 months between the operation
dates of patient 3 and 5. It is not possible to define a
traceable source of infection among those sequen-
tially transplanted recipients; there were different
genotypes and unrelated HCV sequences in phy-
logenetic analysis.
Type Ib sequences in group II: 9, 10 and 13
clustered together despite the inclusion of a large
dataset of epidemiologically unrelated type 1b
sequences indicating that the patients were
infected with a common variant of HCV. Patients
10 and 13 were a donor-recipient couple as shown
in Table 2.
It had been questioned if there was any carry-
over between the donor and recipient such as
surgeons going between the recipient and donor
with the same gloves. Genotypes and nucleic acid
sequences of HCV isolates from the donor and the
recipient were compared to answer this question.
However, recipients and donors in two couples
were found to be infected with different HCV
genotypes (1b and la, respectively). It is likely that
only one couple was infected with a common
variant of HCV (patients 10 and 13). One recipient
(patient 9) who underwent transplantation a week
before the couple of 10 and 13 was also infected
with this variant. However, it is not possible to tell
the origin of this virus; both of the recipients had
been infected before the transplantations. It is
apparent that the other donors (patients 12 and
14) were infected with other HCV variants.
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sequence, but this sequence was also found in
another unrelated couple's recipient. These data
suggest that multiple breaches in universal infec-
tion control precautions could be responsible for
these HCV infections. None of the staff was
infected with HCV. Infection control procedures
were evaluated by personal interviews with the
medical staff; some poor practices were found
concerning the sterilization, disinfection and uni-
versal infection control procedures used in mana-
ging these patients, including not changing gloves
between patients and insufficient sterilization of
some re-used equipment.
The Organ Transplantation Centre responded
by redoubling educational efforts among the staff,
improving the practice of universal infection con-
trol measures and strictly preventing re-use of
disposable material. This lowered the HCV infec-
tion rate. In 1999, the Central Sterilization Unit
started to function in the hospital under the control
of the Infection Control Committee and no new
cases have been detected since then.
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